Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)—A Bicenter Retrospective Study on Diagnosis, Course, and Therapy
The Journal of Allergy and Clinical Immunology: In Practice · 2023
DOI: 10.1016/j.jaip.2023.09.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2023. Verfasst von Susanne Trainotti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Technical University of Munich, Munich, Germany. Electronic address: susanne.trainotti@tum.de. Hauptthemen laut MEDLINE: Angioedema, Angioedemas, Hereditary. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Acquired angioedema with C1-inhibitor deficiency (AAE-C1-INH) is a rare condition resembling hereditary angioedema (HAE), but with late onset and low C1-inhibitor (C1-INH) due to consumption potentially caused by autoimmune diseases and mainly lymphatic malignancies. Being about 10-fold rarer than HAE, there is limited knowledge and no licensed therapy. OBJECTIVE: To report clinical and biological data from a newly described population of 20 patients with AAE-C1-INH assessing diagnostic delay, AAE-C1-INH:HAE-ratio, underlying conditions, and therapeutic management in Germany. METHODS: Retrospective data analysis of 20 patients from 2 angioedema centers in southern Germany. RESULTS: Median age at symptoms' onset was 64 years (60% females), with predominant swellings of the face (85%) and low levels for C1-INH in almost all patients. The ratio AAE-C1-INH:HAE was 1:9.7. From symptoms' onset to diagnosis of AAE-C1-INH, the median delay was 7.5 months, and between AAE-C1-INH symptoms' onset and diagnosis of the underlying hematological condition (n = 9) it was 4 months (median). Four patients had a history of solid neoplasm, 1 had a papillary thyroid carcinoma as the only potential cause for AAE-C1-INH, with treatment of the malignancy resulting in resolution of AAE-C1-INH. All the symptomatic patients were treated with off-label on-demand icatibant subcutaneously or C1-INH concentrate intravenously, and 6 severely affected patients needed off-label long-term prophylaxis with good symptom control. CONCLUSIONS: AAE-C1-INH is characterized by late-onset swellings mainly involving the face and low C1-INH levels. Diagnostic delay for AAE-C1-INH is further decreasing despite being about 10-fold rarer than HAE. Patients severely affected without underlying condition or no indication for treatment could benefit from off-label therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Technical University of Munich, Munich, Germany. Electronic address: susanne.trainotti@tum.de.
- University Hospital for Otorhinolaryngology, Head and Neck Surgery, Medical University of Innsbruck, Innsbruck, Austria.
- Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.
- Department of Otorhinolaryngology, Technical University of Munich, Munich, Germany.
Zitieren
APA
Trainotti, S., Johnson, F., Hahn, J., Hofauer, B., Greve, J., Wollenberg, B., Hoffmann, T. K., & Lochbaum, R. (2023). Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)—A Bicenter Retrospective Study on Diagnosis, Course, and Therapy. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2023.09.003
Vancouver
Trainotti S, Johnson F, Hahn J, Hofauer B, Greve J, Wollenberg B, et al. Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)—A Bicenter Retrospective Study on Diagnosis, Course, and Therapy. The Journal of Allergy and Clinical Immunology: In Practice. 2023. doi:10.1016/j.jaip.2023.09.003
BibTeX
@article{Trainotti2023,
author = {Trainotti, Susanne and Johnson, Felix and Hahn, Janina and Hofauer, Benedikt and Greve, Jens and Wollenberg, Barbara and Hoffmann, Thomas K and Lochbaum, Robin},
title = {Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)—A Bicenter Retrospective Study on Diagnosis, Course, and Therapy},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2023},
doi = {10.1016/j.jaip.2023.09.003}
}
EUVIMED